Fig. 5. The expression of LINC00263 is sex-specific in cancers.
a The expression of LINC00263 increased in 473 colon cancer tumor tissues compared to 41 normal tissue in the TCGA database (P < 0.0001). b Comparison of the expression of LINC00263 between 212 female tumor tissue and 235 male tumor tissues (P = 0.04). c–e Kaplan–Meier curves for overall survival rates associated with LINC00263 expression in colon cancers (low expression numbers = 140, high expression numbers = 129) c and females (low expression number = 28, high expression number = 47) d and males (low expression number = 32, high expression number = 58). f The expression of LINC00263 increased in 819 renal cell carcinoma tumor tissues compared to 113 normal tissue in the TCGA database (P < 0.0001). g Comparison of the expression of LINC00263 between 194 female tumor tissue and 396 male tumor tissues (P = 0.003). h–j Kaplan–Meier curves for overall survival rates associated with LINC00263 expression in renal cell carcinoma (low expression numbers = 418, high expression numbers = 399) h and females (low expression number = 155, high expression number = 107) i and males (low expression number = 298, high expression number = 257) j. k The expression of LINC00263 increased in 411 Hepatocellular carcinoma tumor tissues compared to 58 normal tissue in the TCGA database (P = 0.001). l–n Comparison of the expression of LINC00263 between normal tissues and tumor tissues in female (P = 0.08)(l) and in males (P = 0.006) m and between 120 female tumor tissues and 249 male tumor tissues (P = 0.38) n. o, p Kaplan–Meier curves for overall survival rates associated with LINC00263 expression in females (low expression number = 77, high expression number = 44) o and males (low expression number = 66, high expression number = 183) p. q The expression of LINC00263 increased in 499 prostate cancer tumor tissues compared to 52 normal tissue in the TCGA database (P = 0.005). r Kaplan–Meier curves for overall survival rates associated with LINC00263 expression in prostate cancer (low expression number = 247, high expression number = 248). s The expression of LINC00263 increased in 12 ovarian cancer normal tissues compared to 12 tumor tissue in the GEO database (GSE14407) (P = 0.01). t Kaplan–Meier curves for overall survival rates associated with LINC00263 expression in ovarian cancer (low expression number = 174, high expression number = 199). u The expression of LINC00263 increased in 1071 breast cancer tumor tissues compared to 98 normal tissue in the TCGA database (P = 0.007). v Comparison of the expression of LINC00263 between 1059 female tumor tissue and 12 male tumor tissues (P = 0.01). w Kaplan–Meier curves for overall survival rates associated with LINC00263 expression in breast cancer (low expression number = 354, high expression number = 723). Data are shown as the mean ± SEM; n ≥ 3 independent experiments, two-tailed Student’s t-test: ns nonsignificant (P > 0.05), *P < 0.05, **P < 0.01, ***P < 0.001.